Grayce Selig
Medical Oncology · Paoli, PANPI 1497242069
Payments from drug & device makers
Across 34 payments — averaging $51.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AstraZeneca$78
- Tempus AI, Inc$62
- Pfizer$37
- AVEO Pharmaceuticals, Inc.$34
- Eisai Inc.$32
- plus $164 from 8 others
What the payments were for
- Food & beverage$54231%
- Other$1,19669%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $1,332 |
| AstraZeneca | 3 | $78 |
| Tempus AI, Inc | 1 | $62 |
| Pfizer | 2 | $37 |
| AVEO Pharmaceuticals, Inc. | 1 | $34 |
| Eisai Inc. | 1 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $31 |
| Puma Biotechnology, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $21 |
| GSK | 1 | $19 |
| Array Biopharma Inc | 1 | $19 |
| Merck | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Incyte Corporation | 1 | $14 |
How this compares
$1,738 in reported general payments places this provider in the 30th percentile of 238 medical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Paoli
- Sukhmani PaddaPhiladelphia$25.6M
- Peter O DwyerPhiladelphia$18M
- Margaret von MehrenPhiladelphia$17.4M
- Kim Reiss BinderPhiladelphia$16.9M
- Carl JunePhiladelphia$13M
- Takami SatoPhiladelphia$11.5M
- Vivek NarayanPhiladelphia$10.6M
- Ubaldo Martinez-OutschoornPhiladelphia$10.5M
- Neil PalmisianoPhiladelphia$10.1M
- Anthony OlszanskiPhiladelphia$9.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.